Graft Dysfunction and Management in Liver Transplantation
- PMID: 30447775
- DOI: 10.1016/j.ccc.2018.08.002
Graft Dysfunction and Management in Liver Transplantation
Abstract
Graft dysfunction of the liver allograft manifests across a spectrum in both timing posttransplantation and clinical presentation. This can range from mild transient abnormalities of liver tests to acute liver failure potentially leading to graft failure. The causes of graft dysfunction can be divided into those resulting in early and late graft dysfunction. Although nonspecific, liver biochemistry abnormalities are still the mainstay investigation used in monitoring for dysfunction. This article provides a summary of the main causes and management strategies for liver graft dysfunction in the early through late posttransplant stages.
Keywords: Cholestasis; Graft dysfunction; Liver transplantation; Rejection.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.Transplant Proc. 2012 Jun;44(5):1303-6. doi: 10.1016/j.transproceed.2012.01.115. Transplant Proc. 2012. PMID: 22664005
-
Critical Care Management of Living Donor Liver Transplants.Crit Care Clin. 2019 Jan;35(1):107-116. doi: 10.1016/j.ccc.2018.08.001. Epub 2018 Oct 25. Crit Care Clin. 2019. PMID: 30447773 Review.
-
Perioperative Management of the Liver Transplant Recipient.Crit Care Clin. 2019 Jan;35(1):95-105. doi: 10.1016/j.ccc.2018.08.012. Crit Care Clin. 2019. PMID: 30447783 Review.
-
Management of the Liver Transplant Recipient: Approach to Allograft Dysfunction.Med Clin North Am. 2016 May;100(3):477-86. doi: 10.1016/j.mcna.2016.01.001. Epub 2016 Mar 17. Med Clin North Am. 2016. PMID: 27095640 Review.
-
A new index predicts early allograft dysfunction following living donor liver transplantation: A propensity score analysis.Dig Liver Dis. 2017 Nov;49(11):1225-1232. doi: 10.1016/j.dld.2017.06.007. Epub 2017 Jun 23. Dig Liver Dis. 2017. PMID: 28750872
Cited by
-
Hepatic ischemia-reperfusion syndrome and its effect on the cardiovascular system: The role of treprostinil, a synthetic prostacyclin analog.World J Gastrointest Surg. 2023 Sep 27;15(9):1858-1870. doi: 10.4240/wjgs.v15.i9.1858. World J Gastrointest Surg. 2023. PMID: 37901735 Free PMC article. Review.
-
Association between the donor to recipient ICG-PDR variation rate and the functional recovery of the graft after orthotopic liver transplantation: A case series.PLoS One. 2021 Aug 27;16(8):e0256786. doi: 10.1371/journal.pone.0256786. eCollection 2021. PLoS One. 2021. PMID: 34449820 Free PMC article.
-
Procalcitonin in early allograft dysfunction after orthotopic liver transplantation: a retrospective single centre study.BMC Gastroenterol. 2022 Aug 31;22(1):404. doi: 10.1186/s12876-022-02486-5. BMC Gastroenterol. 2022. PMID: 36045337 Free PMC article.
-
Application of ischaemia-free liver transplantation improves prognosis of patients with steatotic donor livers - a retrospective study.Transpl Int. 2021 Jul;34(7):1261-1270. doi: 10.1111/tri.13828. Epub 2021 Jun 7. Transpl Int. 2021. PMID: 33484201 Free PMC article.
-
[Effect of artificial liver with double plasma molecular absorb system model on patients' platelets and corresponding treatment strategy].Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Jun 18;54(3):548-551. doi: 10.19723/j.issn.1671-167X.2022.03.022. Beijing Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 35701134 Free PMC article. Chinese.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical